Literature DB >> 15142043

Long time follow up of CD28- CD4+ T cells in living kidney transplant patients.

M Kato1, Y Ono, T Kinukawa, R Hattori, O Kamihira, S Ohshima.   

Abstract

We previously reported that the CD28(-) CD4(+) T cell subpopulation was expanded in the kidney allograft patients with long graft survival, although these T cells were rarely found in patients with graft survival <5 yr. To understand the CD28(-) CD4(+) T cells in the long-term acceptance of kidney allografts, we examined functions of this population and performed a 4 yr follow up study. Peripheral blood mononuclear cells (PBMC) were obtained from 47 long-term living related kidney allograft recipients. CD28(+) CD4(+) and CD28(-) CD4(+) T cells purified by cell sorting were analyzed for expression of V(beta) repertoire. Donor-specific response was examined in mixed lymphocyte reaction (MLR). A follow up study with long-term kidney allograft patients was performed for 4 yr about the rate of CD28(-) CD4(+) T cells. Eleven patients were examined by MLRs against donors and third party. Four patients with a marked increase of CD28(-) CD4(+) T cells showed the donor-specific responses appeared to be lower when compared with third party-specific responses. Freshly sorted CD28(-) CD4(+) T cells showed a restricted V(beta) repertoire, whereas the V(beta) usage of CD28(+) CD4(+) T cells from the same patients was much diversified. Such difference in V(beta) repertoire was not evident between the two populations from healthy control. A follow up study showed the ratio of CD28(-) CD4(+) T cells appeared to be lower in patients who were suspected of chronic rejection. These unusual CD4(+) T cells might be related to the long-term acceptance of human transplant allografts.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15142043     DOI: 10.1111/j.1399-0012.2004.00143.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  5 in total

1.  Lymph node and circulating T cell characteristics are strongly correlated in end-stage renal disease patients, but highly differentiated T cells reside within the circulation.

Authors:  B Dedeoglu; A E de Weerd; L Huang; A W Langerak; F J Dor; M Klepper; W Verschoor; D Reijerkerk; C C Baan; N H R Litjens; M G H Betjes
Journal:  Clin Exp Immunol       Date:  2017-02-28       Impact factor: 4.330

2.  Increased Pretransplant Frequency of CD28+ CD4+ TEM Predicts Belatacept-Resistant Rejection in Human Renal Transplant Recipients.

Authors:  M Cortes-Cerisuelo; S J Laurie; D V Mathews; P D Winterberg; C P Larsen; A B Adams; M L Ford
Journal:  Am J Transplant       Date:  2017-06-30       Impact factor: 8.086

3.  TIGIT regulates apoptosis of risky memory T cell subsets implicated in belatacept-resistant rejection.

Authors:  He Sun; Christina R Hartigan; Ching-Wen Chen; Yini Sun; Marvi Tariq; Jennifer M Robertson; Scott M Krummey; Aneesh K Mehta; Mandy L Ford
Journal:  Am J Transplant       Date:  2021-05-27       Impact factor: 9.369

Review 4.  The effect of chronic kidney disease on T cell alloimmunity.

Authors:  Pamela D Winterberg; Mandy L Ford
Journal:  Curr Opin Organ Transplant       Date:  2017-02       Impact factor: 2.640

5.  Loss of CD28 on Peripheral T Cells Decreases the Risk for Early Acute Rejection after Kidney Transplantation.

Authors:  Burç Dedeoglu; Ruud W J Meijers; Mariska Klepper; Dennis A Hesselink; Carla C Baan; Nicolle H R Litjens; Michiel G H Betjes
Journal:  PLoS One       Date:  2016-03-07       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.